Zone 2 Training & VO₂max: What the Trials Actually Measured

Two terms do most of the work in this guide. Both deserve clean definitions before any training advice.

VO₂max is your body's ceiling on oxygen uptake during all-out exercise, measured in mL per kg per minute. It is the single best lab summary of cardiorespiratory fitness. To measure it directly, you do a Spiroergometrie (the lab test where you breathe into a mask while cycling or running flat-out). The Norwegian reference dataset (Loe H, Rognmo Ø, Saltin B, Wisløff U. 2013 PLoS ONE 8(5):e64319) sampled 3,816 healthy adults aged 20 to 90. Twenty-something men averaged 54.4 ± 8.4, women 43.0 ± 7.7. Both sexes drop about 3.5 mL per kg per minute every decade. This is the dataset your Garmin or Apple Watch is silently comparing you to.

Zone 2 is a training-intensity label, not a physiological constant. The framework comes from Skinner JS, McLellan TM. 1980 Research Quarterly for Exercise and Sport to 248. They described three phases of exercise: phase 1 (lactate stays near baseline), phase 2 (lactate rises modestly to about 2 mmol per litre, the first or aerobic threshold LT1/VT1), and phase 3 (lactate climbs non-linearly above 4 mmol per litre, the anaerobic threshold LT2/VT2). Today, Zone 2 means training below LT1. In practice that is a sustained blood lactate of roughly 1.5 to 2.0 mmol per litre, heart rate around 60 to 75 percent of max in untrained-to-moderately-trained adults, and an effort you would describe as "talking but not singing."

Here is the catch. The threshold is a band, not a line. Faude O, Kindermann W, Meyer T. 2009 Sports Medicine to 490 reviewed 25 different lactate-threshold concepts. The same athlete gets different threshold numbers depending on which definition the lab picks (Mader, Stegmann, Dickhuth, IAT, lactate-minimum, MLSS, VT1, VT2). Practical takeaway: a Spiroergometrie or Laktattest report from a German Sportmedizin clinic should name the concept it used. Comparing reports across labs only works if you know the concept.

The biochemistry under the label is much older than the marketing. Brooks GA. 2018 Cell Metabolism to 785 is the canonical paper on lactate-shuttle theory. Lactate is not waste. It is a primary fuel and signalling molecule, produced in glycolytic fibres, transported via MCT1 (a transporter protein) into oxidative fibres and the mitochondrion, and burned. The "Zone 2 trains lactate clearance" pedagogy popularised by Iñigo San Millán rests on this 50-year-old framework. Brooks first proposed it in 1985.

The mitochondrial side is just as old. Holloszy JO. 1967 Journal of Biological Chemistry to 2282. Endurance training in rats roughly doubled the mitochondrial content of skeletal muscle and its respiratory enzymes. Forty years before Zone 2 had a marketing label, the biochemistry was on record. Holloszy and Coyle 1984 J Appl Physiol to 838 added the metabolic consequences: lower lactate at any given workload, more fat oxidation, less glycogen burned. That substrate shift is what people now rebrand as metabolic flexibility.

The honest summary. VO₂max is a directly measurable physiological ceiling. Zone 2 is a training-intensity band whose definition depends on which threshold concept the lab uses. The underlying biochemistry has been settled for four to six decades.

Cardiorespiratory fitness predicts how long you live better than almost anything else we can measure. That is the observational finding. How much of that signal you can move by training is a separate, less settled question.

The headline paper is Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber WA. 2018 JAMA Network Open. Retrospective Cleveland Clinic cohort, 122,007 patients on a treadmill between 1991 and 2014, followed a median of 8.4 years, 13,637 deaths. Patients were sorted into five fitness groups by age- and sex-adjusted percentile. The adjusted hazard ratio for low-fitness versus elite-fitness was 5.04 (95% CI 4.10 to 6.20, P <.001). In the same model, smoking gave HR 1.41, type 2 diabetes 1.40, coronary artery disease 1.29. The verbatim conclusion: "Cardiorespiratory fitness is inversely associated with long-term mortality with no observed upper limit of benefit."

That is where the popular line "being unfit is worse for you than smoking" comes from. It is a fair reading of Mandsager 2018 Table 3.

The replication. Kokkinos P, Faselis C, Samuel IBH, et al. 2022 Journal of the American College of Cardiology to 609. US Veterans cohort, n = 750,302, mean age 61.3, median follow-up 10.2 years, 174,807 deaths. Same inverse, graded fitness-to-mortality relationship across age, sex, and race subgroups, including people in their 70s and 80s, African Americans, Hispanics, and women. Optimal fitness sat around 14 METs (metabolic equivalents of resting oxygen use) in both sexes. The bottom-20th-percentile fitness group had roughly four times the mortality of the extremely fit. No increase in mortality risk at very high fitness. That closes the "too much exercise will kill you" argument for measured METs.

The 46-year follow-up. Clausen JSR, Marott JL, Holtermann A, Gyntelberg F, Jensen MT. 2018 JACC to 995. Copenhagen Male Study, 5,107 middle-aged men enrolled 1970 to 1971, followed for 46 years, 4,700 deaths. Each one-unit-higher VO₂max at midlife translated to roughly 45 extra days of life expectancy. The above-upper-limit-of-normal fitness group lived 4.9 extra years versus 2.1 in the low-normal group, a delta of about 2.8 years between groups. The effect held after excluding deaths in the first decade of follow-up. That partially addresses the reverse-causation worry that haunts shorter cohorts.

The original cohort. Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW. 1989 JAMA to 2401. The Aerobics Center Longitudinal Study (ACLS), n = 13,344, mean follow-up 8.1 years. Age-adjusted all-cause mortality per 10,000 person-years dropped from 64.0 in the least fit men to 18.6 in the most fit, and from 39.5 to 8.5 in women. The effect survived adjustment for smoking, cholesterol, blood pressure, glucose, and family history. Blair has been the field's most influential investigator for almost four decades. Almost every modern "exercise is medicine" framework leans on ACLS.

The Scientific Statement. Ross R, Blair SN, Arena R, et al. 2016 Circulation to e699. AHA Scientific Statement: "Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign." The verbatim line: "CRF is a potentially stronger predictor of mortality than established risk factors such as smoking, hypertension, high cholesterol, and type 2 diabetes mellitus." The Statement formally argues for routine CRF assessment in clinical practice. As of 2026, that has not made its way into routine US or DACH primary care.

Now the honest caveats. They matter.

• All observational. None of these studies randomised people to fitness. They measured fitness and counted deaths.
• Reverse causation is hard to rule out. Sicker people exercise less and score lower on fitness. The underlying disease then lowers both fitness and survival. Clausen's 46-year follow-up partially addresses this. Mandsager 2018, at 8.4 years, addresses it less.
• Cohort selection. Mandsager was a clinical referral cohort. Kokkinos was a Veterans cohort. Neither is a random sample of the general population.
• Treadmill peak METs is an estimate, not a directly measured VO₂max. Most large cohorts use estimated METs from a treadmill protocol, not direct gas exchange.
• The honest editorial frame is "fitness is the strongest measured marker," not "raising your fitness by X will raise your survival by Y." The second claim requires RCT evidence we do not have at scale.

The one large RCT that tested structured exercise versus guidelines for all-cause mortality (Generation 100, Section 5) was null on its primary endpoint. The mechanism is solid. The cross-sectional evidence is overwhelming. The interventional translation is more modest than the headlines suggest.

The mechanistic case for Zone 2 sits on three layers of biochemistry: lactate-shuttle theory, exercise-driven mitochondrial biogenesis, and substrate-utilisation shifts. All three are old, settled, and unambiguous. The popular framing that Zone 2 specifically targets mitochondrial machinery in a way other intensities cannot is where the evidence gets thinner.

Layer 1: the lactate shuttle. Brooks GA. 2018 Cell Metabolism to 785. Lactate produced in glycolytic muscle fibres is carried by MCT1 (a transporter) into oxidative fibres, burned in mitochondria, and used as a cell-to-cell and tissue-to-tissue fuel and signal. The mitochondrial lactate oxidation complex (MCT1 plus LDH plus cytochrome oxidase) is the machinery that the "Zone 2 trains lactate clearance" framing points at.

Layer 2: mitochondrial biogenesis. Holloszy 1967 JBC (rats, endurance training, mitochondrial content doubled). Then Holloszy & Coyle 1984 J Appl Physiol (the consequences: less lactate per workload, more fat oxidation, glycogen sparing). Forty years of follow-up consistently shows endurance training raises mitochondrial content through PGC-1α-driven transcription of nuclear-encoded mitochondrial genes plus coordinated mtDNA replication.

Layer 3: substrate use in elite endurance athletes. San-Millán I, Brooks GA. 2018 Sports Medicine to 479. The paper compared three groups: pro endurance athletes, moderately active people, and metabolic-syndrome patients. Fat oxidation was higher and blood lactate lower in elite athletes (p < 0.01). Within each group, fat oxidation and lactate were strongly inversely correlated: r = -0.97 in athletes, r = -0.98 in moderately active, r = -0.92 in metabolic syndrome (all p < 0.01).

This is the most-cited primary paper in the Zone-2 popularisation lineage. What it actually showed: cross-sectional differences in substrate use by fitness level. What it did not show: that training at Zone 2 specifically produces those differences (the causal claim is borrowed from Holloszy 1967), or that Zone 2 outperforms equivalent-volume higher-intensity training for any clinical outcome. The paper neither prescribes a Zone 2 dose nor demonstrates Zone 2 superiority over alternatives on hard endpoints.

Now the honest counter-position. MacInnis MJ, Gibala MJ. 2017 Journal of Physiology to 2930. "Physiological adaptations to interval training and the role of exercise intensity." The argument: sprint interval training (SIT) and high-intensity interval training (HIIT) produce comparable mitochondrial adaptations to moderate-intensity continuous training (MICT) at a fraction of the time. The empirical anchor is Burgomaster KA, Howarth KR, Phillips SM, Rakobowchuk M, Macdonald MJ, McGee SL, Gibala MJ. 2008 J Physiol to 160. Six weeks of SIT at about 1.5 hours per week versus traditional endurance training at about 4.5 hours per week produced similar gains in mitochondrial markers, similar drops in glycogen use, similar rises in fat oxidation.

MacInnis & Gibala's punchline: when total training time is the binding constraint, intervals match steady endurance for mitochondrial adaptation per unit time. This is the McMaster-lab counter-evidence to the "Zone 2 specifically" framing.

The honest Zone 2 defence, then, is not that Zone 2 trains mitochondria better than HIIT per minute. It is that Zone 2 is the highest tolerable training volume, and total volume drives total mitochondrial content. You can do six hours per week of Zone 2. You cannot do six hours per week of 4×4 intervals. Bishop & Granata 2014 Biochimica et Biophysica Acta (cited in the Mitochondria guide) reach a synthesis: volume drives mitochondrial content. Intensity drives mitochondrial function per unit mitochondrion. Both matter. They are not interchangeable.

Where the evidence is still thin. The clean intervention trial, Zone-2-only versus HIIT-only versus polarised, matched for total energy expenditure, with mortality or all-cause-disability endpoints over 5 to 10 years, does not exist. The mechanistic biology is unambiguous. The translation to hard outcomes via Zone 2 specifically is mechanism plus observation, not RCT-proven against equivalent-volume HIIT.

VO₂max is highly trainable. The most-replicated protocol for moving it is the Norwegian 4×4 interval, developed at NTNU Trondheim.

The reference paper. Helgerud J, Høydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, Simonsen T, Helgesen C, Hjorth N, Bach R, Hoff J. 2007 Medicine & Science in Sports & Exercise to 671. RCT, n = 40 moderately trained men around 24 years old, baseline VO₂max 55.5 to 60.5 across arms. Four arms, 8 weeks, 3 days per week, matched for total oxygen consumption:

• Long slow distance (LSD, about 70% HRmax): VO₂max change not significant
• Lactate-threshold training (about 85% HRmax): VO₂max change not significant
• 15/15 intervals (15 s at 90 to 95% HRmax / 15 s active recovery): +5.5% VO₂max
• 4×4 minute intervals (4 min at 90 to 95% HRmax / 3 min active recovery): +7.2% VO₂max (55.5 to 60.4)
• Stroke volume rose about 10% after intervals. No rise after LSD or LT.

This is the modern reference for "intervals beat steady-state for VO₂max gains per minute" in healthy adults. Eight weeks. Three sessions per week. Roughly 7% VO₂max gain in already-moderately-trained men.

The strongest clinical signal. Wisløff U, Støylen A, Loennechen JP, et al. 2007 Circulation to 3094. "Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients." n = 27 post-infarction NYHA-class heart-failure patients, mean age 75.5, baseline LVEF (left-ventricular ejection fraction) 29%, baseline VO₂peak 13. Twelve weeks, three sessions per week:

• 4×4 intervals at 95% peak HR: VO₂peak +46%
• Moderate continuous at 70% peak HR: VO₂peak +14%
• LV end-diastolic and end-systolic volumes dropped 18% and 25% with intervals (reverse cardiac remodelling)
• LVEF rose 35% with intervals
• Pro-BNP fell 40%
• Endothelial function improved more with intervals

Verbatim conclusion: "Exercise intensity was an important factor for reversing LV remodeling and improving aerobic capacity, quality of life, and endothelial function in postinfarction heart failure patients." Counter-intuitively, the strongest RCT signal for "intervals matter" comes from heart-failure patients, not healthy older adults.

The meta-analysis. Bacon AP, Carter RE, Ogle EA, Joyner MJ. 2013 PLoS ONE. 37 studies, 40 training groups, 334 subjects (120 women). Pooled random-effects VO₂max change: +0.51 L per minute (95% CI 0.43 to 0.60), standardised effect 0.86 SD (0.72 to 0.99). The biggest source of between-study variance was baseline fitness. Sedentary participants gained more. Well-trained athletes less.

Polarised structure. Stöggl T, Sperlich B. 2014 Frontiers in Physiology 5:33. RCT, n = 48 well-trained endurance athletes, 9 weeks, four arms:

• Polarised (POL, about 80% below LT1, about 20% above LT2): VO₂peak +11.7% (p < 0.001), time to exhaustion +17.4%, peak power/velocity +5.1%, velocity/power at 4 mmol per litre lactate +8.1%
• High-volume threshold training: minimal gains
• High-intensity-only training: minimal gains
• High-volume training only: minimal gains

This is the closest thing to a positive RCT for polarised training in trained athletes. The observational basis comes from Seiler S. 2010 International Journal of Sports Physiology and Performance to 291. Across elite endurance athletes (rowers, cyclists, cross-country skiers, runners), about 80% of training sessions sit below LT1 and about 20% sit above LT2, with very little time in the threshold zone in between. That 80/20 polarised pattern is the empirical foundation behind both Attia's framing and the broader polarised-training movement.

Stacking the protocols, honestly. Helgerud 2007 plus Wisløff 2007 plus Bacon 2013 plus Stöggl & Sperlich 2014 together make a strong physiological case: (a) VO₂max is trainable in 8 to 12 weeks, (b) high-intensity intervals dominate per unit time, (c) polarised structures (mostly low intensity plus a small high-intensity dose) beat threshold-only or high-volume-only in trained athletes, and (d) intervals are clinically useful in established cardiovascular disease. None of these are mortality trials. The mortality data are observational (Section 2). The single RCT that tested structured training versus guidelines for mortality (Generation 100, next section) was null on the primary endpoint.

Every popular Zone 2 narrative has to deal with one awkward fact. The only large RCT of structured exercise versus guidelines that measured all-cause mortality directly in older adults was null on its primary endpoint.

Stensvold D, Viken H, Steinshamn SL, et al. 2020 BMJ 371:m3485. The Generation 100 trial. n = 1,567 Norwegians born 1936 to 1942 (790 women), mean age 72.8 at randomisation. Three arms, 5 years:

• Control (n = 780): follow national physical-activity guidelines
• MICT (n = 387): moderate-intensity continuous training at about 70% peak HR
• HIIT (n = 400): high-intensity interval training at about 90% peak HR using the 4×4 protocol

Primary endpoint at 5 years (all-cause mortality):

• All-cause mortality 4.6% overall (control 4.7%, MICT 5.9%, HIIT 3.0%)
• Combined MICT + HIIT vs control: HR 1.08 (95% CI 0.71 to 1.66; P = 0.72). NULL.
• HIIT vs control: HR 0.63 (0.33 to 1.20; P = 0.16). Non-significant trend favouring HIIT.
• HIIT vs MICT: HR 0.51 (0.25 to 1.02; P = 0.06). Non-significant trend favouring HIIT.

Verbatim conclusion: "This study suggests that combined MICT and HIIT has no effect on all cause mortality compared with recommended physical activity levels. However, we observed a lower all cause mortality trend after HIIT compared with controls and MICT."

What this means, honestly. Five years of structured, supervised, high-quality exercise on top of meeting national guidelines did not move all-cause mortality in 70-somethings. The reason is not "exercise doesn't help." The reason is that the control arm was already exercising. Over 80% of control-arm participants met the Norwegian national PA recommendation. So Generation 100 was not a trial of exercise versus no exercise. It was a trial of more structured exercise versus a guidelines-meeting baseline. And at 5 years with n = 1,567, it was underpowered to detect an absolute risk difference of less than one percentage point.

The HIIT-versus-MICT trend (HR 0.51, P = 0.06) is the directional signal that has been picked up in follow-up cause-specific-mortality papers from the same group. It is suggestive, not significant. The honest framing: the trial's primary endpoint was null, the directional trend favoured intervals, and we have no larger or longer mortality RCT to settle the question.

Why this matters for the Zone 2 / VO₂max story. Most popular framing of Zone 2 plus 4×4 as a longevity intervention quietly assumes two things. One, that the observational fitness-mortality gradient is causal at the individual level. Two, that structured training can move people up the gradient. The first claim is biologically plausible but partly confounded by reverse causation. The second claim needed Generation 100 to prove it, and Generation 100 did not. The mechanism is solid. The cross-sectional CRF-mortality association is overwhelming. The interventional translation in a population already meeting guidelines is, at 5 years, null.

This is the single most important honest fact in this guide. It does not invalidate the rationale for Zone 2 plus intervals. It does mean that the "this protocol will give you 10 extra healthy years" claim, repeated across YouTube and podcasts in 2024 to 2026, has thinner RCT support than the framing suggests. The 2-to-5-year life-expectancy estimates come from observational cohorts (Clausen 2018, Wen 2011, Lee 2014) with standard reverse-causation caveats. Not from interventional trials with hard endpoints.

Peter Attia's exercise prescription, drawing on the mechanistic framing developed by Iñigo San Millán (University of Colorado, Tour de France medical director), is the most influential lay synthesis of the Zone 2 plus VO₂max story in 2026. Published in Outlive: The Science and Art of Longevity (Harmony / Penguin Random House, 2023) and elaborated across The Peter Attia Drive podcast, especially episode #201 (Iñigo San Millán on Zone 2) and #261 (the Centenarian Decathlon framework).

The recommendation, summarised.

• Cardiovascular training time: 3 to 4 hours per week minimum, 5 to 6 ideal
• About 80% of that time in Zone 2 (intensity below LT1, lactate around 1.7 to 2.0 mmol per litre, "talking but not singing")
• About 20% at VO₂max-targeting intensity, typically the Norwegian 4×4 protocol once per week
• Zone 2 sessions: 30 to 60 minutes each, 3 to 4 per week (total Zone 2 about 2 to 4 hours)
• One VO₂max session of about 30 minutes including warm-up (the 4×4)
• Lift weights three times per week separately, for the Decathlon's strength and bone goals

What's solid in this framing.

• The 80/20 polarised structure has the strongest endurance-athlete RCT support (Stöggl & Sperlich 2014 Front Physiol) and the strongest observational backbone in elite endurance athletes (Seiler 2010 IJSPP).
• The 4×4 protocol has the strongest VO₂max-improvement evidence in both healthy adults (Helgerud 2007 MSSE) and heart-failure patients (Wisløff 2007 Circulation).
• The mechanistic rationale (Brooks 2018 Cell Metabolism on the lactate shuttle, Holloszy 1967 JBC on mitochondrial biogenesis, Bishop & Granata 2014 BBA on volume versus intensity adaptation) is solid four-to-six-decade-old biochemistry.
• The behavioural-design value of the Centenarian Decathlon framing (pick ten physical capabilities you want at 90 and reverse-engineer your training to them) is a legitimate goal-setting heuristic.

What's marketing-style overstatement.

1. "Zone 2 specifically targets the mitochondrial machinery in a way HIIT can't replicate." The directly comparative human evidence is not there. Burgomaster 2008 J Physiol and MacInnis & Gibala 2017 J Physiol are the honest counter-position: SIT and HIIT produce comparable mitochondrial adaptations to MICT at a fraction of the time. The Zone 2 defence is "Zone 2 is the highest tolerable training volume, and volume drives total content". Not "Zone 2 trains mitochondria in a unique way."

2. "This protocol will give you 10 extra healthy years." Not RCT-proven. Generation 100 (Stensvold 2020 BMJ) was null on its primary endpoint at 5 years. The 2-to-5-year life-expectancy estimates come from observational cohorts (Clausen 2018, Wen 2011, Lee 2014) with reverse-causation caveats. Attia generally acknowledges these caveats more carefully in long-form interviews than the podcast-clip aggregators do.

3. "The Centenarian Decathlon is an evidence-based clinical framework." It is a behavioural-design heuristic, not a clinical-trial endpoint. It works the way the FRAX score works in osteoporosis: a structured way to frame decisions, not a validated risk-prediction instrument.

Attia's role, accurately stated. Attia did not invent Zone 2. He did not invent the 4×4 protocol or polarised training. He popularised an existing framework that ties together San Millán's lactate-clearance pedagogy, the Norwegian NTNU interval literature (Helgerud, Wisløff, Stensvold), Seiler's polarised observation, and the older Holloszy/Brooks biochemistry. The framework is useful. The marginal scientific contribution is the lay-readable synthesis and the behavioural-design framing (Centenarian Decathlon, training as preparation for the marginal decade), not new physiology.

The editorial position this guide takes: cite Attia and San Millán as popularisers. Cite Holloszy, Brooks, and Bishop for the actual physiology. Cite Helgerud, Wisløff, and Stöggl for the interval protocols. Cite Generation 100, Mandsager, and Kokkinos for the mortality data. And be explicit that the Zone-2-is-the-longevity-zone framing is mechanism plus observational support, not RCT-proven against equivalent-volume HIIT.

Zone 2 is the band below your first lactate threshold (LT1), the intensity at which lactate begins to rise modestly above baseline. To pin it down precisely, you need a Spiroergometrie plus Laktatstufentest at a Sportmedizin lab (Section 8). Most people can get into defensible Zone 2 territory without one, using practical surrogates. Here are the options, ranked by honest accuracy.

1. Direct blood lactate (gold standard). Capillary lactate of 1.5 to 2.0 mmol per litre sustained equals Zone 2 in most definitions. You need a handheld lactate analyser (Lactate Plus, Lactate Scout, EKF Biosen), roughly €350 to €700 retail in DACH, plus disposable strips at about €1 to €1.50 each, plus the willingness to do finger sticks. You take a sample at the end of each interval at rising intensities to map your personal lactate-to-power or lactate-to-pace curve. This is the field equivalent of what a Sportmedizin lab does, minus the gas-exchange measurement.

2. Power-based prescription via smart trainer. Wahoo Kickr (Core / V6 / Move) and Tacx Neo 3M / Flux 2 (Garmin-owned, Dutch-engineered) are the dominant direct-drive smart trainers in DACH. Both broadcast power, cadence, and (with a paired HR strap) heart rate via ANT+ and Bluetooth to Zwift, MyWhoosh, TrainerRoad, and Rouvy. Power accuracy is typically ±1 to 2% versus calibrated lab ergometers. That is an order of magnitude better than wrist-VO₂max estimates. If you have either a lab-test FTP (functional threshold power) or a structured 20-min FTP-estimation as your anchor, Zone 2 is roughly 55 to 75% of FTP, depending on which model you use (Coggan, Friel, San Millán, Seiler). Typical 2026 DACH prices: Kickr Core around €700, Kickr V6 around €1,200, Kickr Move around €1,600, Tacx Neo 3M around €1,500. Refurbished and used markets via Bike Discount, Bike24, and eBay Kleinanzeigen.

3. Heart-rate-based prescription. Roughly 60 to 70% HRmax for untrained adults, 70 to 80% HRmax for trained. Less accurate than lactate or power, because individual HR-to-lactate relationships vary a lot and HR drifts upward during long sessions (cardiovascular drift). If you use HR, anchor it with at least one lab test or a periodic field test, to confirm your zones are not drifting with fitness.

4. Talk test / RPE. "Talking but not singing" corresponds to roughly LT1/VT1 in untrained-to-moderately-trained adults. RPE around 11 to 13 on the Borg 6 to 20 scale, or 3 to 4 on the CR-10 scale. Cheap, accessible, surprisingly serviceable as a first approximation. It will under-shoot Zone 2 in well-trained athletes (whose LT1 is at a higher absolute intensity than the conversational threshold catches).

5. The Maffetone 180 minus age formula. Honest caveat. The 180 minus age heart-rate formula (Phil Maffetone, originally from his coaching practice in the 1980s, popularised in The Big Book of Endurance Training and Racing, 2010) has no independent peer-reviewed validation. Maffetone & Laursen's 2020 Frontiers in Physiology article exists, but it is a self-authored review, not third-party validation against lab-measured LT1. The formula tends to produce an aerobic-threshold-territory target HR for many adults, which is broadly Zone-2-ish. The precision people attribute to it is not real. Treat it as a coaching heuristic, not as evidence-based.

Practical prescription for a typical longevity-curious adult. Drawing on Stöggl & Sperlich 2014, Seiler 2010, and Helgerud 2007:

• Volume target: 3 to 5 hours per week of total aerobic work to start. WHO 2020 guidelines (Bull FC et al. 2020 BJSM) ask for 150 to 300 minutes moderate or 75 to 150 minutes vigorous per week as the public-health minimum. The longevity-curious target lives above this.
• Zone 2 sessions: 30 to 60 minutes each, 2 to 4 per week. Bike, run, row, walk uphill, or any modality where you can hold a steady moderate effort. The "talk-not-sing" check should be honest. If you have to pause mid-sentence, you are above Zone 2. If you can recite a poem fluently, you are below it.
• One VO₂max session per week: 4×4 intervals. 10-minute warm-up, 4 minutes at 90 to 95% HRmax, 3 minutes active recovery at about 70% HRmax, repeat four times, 5-minute cool-down. Total about 35 to 40 minutes. This is the Helgerud / Wisløff protocol.
• Strength training: 2 to 3 sessions per week separately. Not covered in this guide. See the Exercise guide for the longevity strength prescription.
• Progression: add 5 to 10 minutes per session per week until you hit your weekly volume target. Then improve quality (raise the Zone 2 power for the same HR, finish the 4th interval at the same pace as the 1st).

The minimum effective dose. Wen CP, Wai JPM, Tsai MK, et al. 2011 Lancet to 1253 found that 92 minutes per week of moderate activity (about 15 minutes per day) gave a 14% drop in all-cause mortality (HR 0.86) and 3 extra years of life expectancy in a Taiwanese cohort of 416,175 adults. Lee D-C, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. 2014 JACC to 481 found that runners (any amount) had 30% lower all-cause mortality and 45% lower CV mortality than non-runners, with the benefit appearing below 51 minutes per week of running. Garcia L, Pearce M, Abbas A, et al. 2023 BJSM to 989 meta-analysed 196 articles, 94 cohorts, over 30 million participants. At 8.75 marginal MET-h per week (about 150 minutes moderate), all-cause mortality RR 0.69. Diminishing returns beyond about 17.5 MET-h per week.

The public-health gradient is steepest from zero to about 150 minutes per week. The longevity-curious DACH reader prioritising Zone 2 plus intervals is already well above the minimum-dose zone. Going from 150 to 300 to 500 minutes per week buys real but progressively smaller marginal benefit.

A Spiroergometrie (cardiopulmonary exercise test, CPET) is the gold-standard direct measurement of VO₂max. It uses breath-by-breath gas analysis (VO₂, VCO₂, RER, VE) during incremental exercise on a cycle ergometer or treadmill, taken to exhaustion or a clinical stopping criterion. Add finger-stick lactate sampling and you also get LT1 and LT2. The full appointment runs 60 to 120 minutes. The test itself is about 20 to 30 minutes. You leave with a written report containing heart-rate, power, and (often) pace zones you can train to.

Honest price band, DACH 2026 (verify before booking):

• Spiroergometrie standalone, Germany Selbstzahler: €200 to €350
• Laktatstufentest standalone, Germany Selbstzahler: €80 to €200 (wide range, cheap end is gyms with handheld analysers, expensive end is Universitäts-Sportmedizin)
• Combined Spiro plus Lactate "Goldstandard", Germany: €250 to €350
• Switzerland Spiroergometrie: CHF 300 to 450
• Switzerland Laktattest: CHF 200 to 280
• Austria: similar to Germany, Selbstzahler default

Verified DACH provider snapshot (2025/2026, verify prices before booking):

• TU München / Klinikum rechts der Isar Sportmedizin (München): Spiroergometrie plus Laktattest, treadmill or cycle ergometer. Reports LT, IAS, VT1, VT2, VO₂max. Over 8,000 tests per year. Price not publicly listed, contact [email protected].
• Charité Sportmedizin (Berlin): Spiroergometrie plus Laktatdiagnostik. Typically €250 to €350 Selbstzahler. GKV covered with a cardiac or respiratory indication.
• The Longevity Practice (Berlin and Frankfurt): VO₂max test from €249.
• Olympiastützpunkt (OSP) Bayern / Berlin / Rheinland / Hessen: Spiroergometrie plus Laktatstufentest in athlete pathways. Limited Selbstzahler slots, variable pricing.
• Schön Klinik München Harlaching Sportmedizin: sportmedizinische Untersuchung, CPET. Selbstzahler around €200 to €350.
• Deutsche Sporthochschule Köln: Leistungsdiagnostik (incl. spiro plus lactate) for the public via Hochschulambulanz. About €200 to €300.
• Zentrum für Sportmedizin Münster (ZfS): sportmedizinische Leistungsdiagnostik, published pricing on site.
• Massimo Köstl-Lenz Leistungsdiagnostik (Wien): Spiroergometrie, Laktattest, VO₂max profile (cycling, running, triathlon). Selbstzahler.
• Hirslanden (Wankdorf Bern, St. Anna Luzern, Geneva Médecine du Sport, Centre Actif+ Lausanne, Pulse & Balance St. Gallen): CPET / VO₂max test at 5 Swiss locations. Typically CHF 350 to 450.
• Balgrist Sportmedizin Universitätsklinik (Zürich): Laktatstufentest CHF 250, Spiroergometrie CHF 350, plus medical-assessment fees (2025 published price list).
• Schulthess Klinik Sportmedizin (Zürich): Spiroergometrie, Laktattest, verify on site.
• Lanserhof / private clinics (Tegernsee, Sylt, Hamburg, Frankfurt): bundled "longevity" CPET plus body composition plus InBody plus bloods. €500 and up as part of premium packages.

Insurance coverage: the honest answer. Spiroergometrie is generally not covered by Krankenkasse (Germany), ÖGK (Austria), or LAMal (Switzerland) for healthy-adult longevity screening. It is covered when there is a documented cardiac, pulmonary, or oncology indication: heart failure, COPD or asthma, pre-operative risk assessment, post-MI rehabilitation, suspected pulmonary hypertension. The Sportmedizinische Vorsorgeuntersuchung (DGSP-style sports-medical check-up) is almost always Selbstzahler.

Krankenkassen-Bonusprogramme (TK Fit, AOK Bonus, DAK Aktiv-Bonus, Barmer Mehr Vorsorge / Bonusprogramm) 2025/2026 reimburse certified prevention courses (§20 SGB V), gym memberships in approved settings, step counts, and routine Vorsorge appointments. That is typically €30 to €150 per year per insured person. They do not specifically reimburse Spiroergometrie or VO₂max testing. A few include reimbursement for a "sportmedizinische Untersuchung" if performed by a DGSP-certified Sportmediziner. Check the current Programm-Bedingungen for each Kasse.

"Rezept für Bewegung." Joint initiative of Bundesärztekammer, DGSP, and DOSB, formally active since 2011 and still running in 2026. A physician writes a non-pharmacological "prescription" for movement that the patient takes to an SQE-certified ("Sport pro Gesundheit") sports club. Useful for behavioural framing but does not trigger Kasse reimbursement of testing.

Pre-participation clearance. Pelliccia A, Sharma S, Gati S, et al. 2020 European Heart Journal to 96. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Pre-participation history plus physical exam is recommended (Class IIa) in adults 35 and over starting vigorous exercise. An exercise test (Spiroergometrie or stress ECG) is recommended before vigorous exercise in adults with known or suspected CAD, multiple risk factors, or symptoms. Routine ECG / stress-test screening of asymptomatic low-risk adults is not universally recommended (Class III in low-risk individuals). This is the framework a DACH GP or Sportmediziner uses when an over-40 reader asks about starting a Zone 2 plus intervals programme.

Apple Watch, Garmin, Polar, Coros, and Whoop all report an estimated VO₂max. The honest frame: trust the trend within yourself, not the absolute number. The individual-level error band against lab Spiroergometrie is roughly ±10 mL per kg per minute.

The systematic review. Molina-Garcia P, Notbohm HL, Schumann M, et al. 2022 Sports Medicine to 1597. The INTERLIVE Network systematic review and meta-analysis of consumer-wearable VO₂max validity, 14 studies pooled:

• Exercise-based algorithms (estimating VO₂max during structured submaximal exercise): bias -0.09 mL per kg per minute, limits of agreement -9.92 to +9.74
• Resting-condition algorithms (estimating VO₂max from resting HR, age, weight): bias +2.17 (they overestimate), wider LoA (-13.07 to +17.41)

In plain terms: exercise-based wearable VO₂max estimates are unbiased on average across a population, but the individual error band is about ±10 mL per kg per minute. Too wide for clinical decisions. Fine for within-person trend tracking.

Apple Watch 2025 validation. Lambe R, O'Grady B, Baldwin M, Doherty C. 2025 PLOS ONE. "Investigating the accuracy of Apple Watch VO₂max measurements." The Apple Watch underestimated VO₂max versus indirect calorimetry by a mean of about 6.07 mL per kg per minute. Direction matters here. An Apple Watch reading of 38 may correspond to a lab value closer to 44.

Polar (Wilkinson 2019). Validity correlation r about 0.64 with treadmill-Bruce VO₂max. Test-retest reliability r about 0.91 (Polar A300 fitness-test feature, Int J Exerc Sci). Reliable (same answer twice) but only moderately valid (the answer differs from lab CPET).

Garmin Firstbeat algorithm. Uses heart rate during walking or running with GPS-derived speed. The literature is mostly industry-internal validations plus a small number of independent studies. Typical individual-level error is ±5 to 8 mL per kg per minute versus lab CPET.

Whoop, Coros, Fitbit. Less peer-reviewed validation literature is available as of 2026. INTERLIVE 2022 found similar individual-level error bands across the major consumer brands.

Honest reader framing. If your Apple Watch says VO₂max moved from 38 to 42 over six months of training, that is a meaningful within-person signal (the trend exceeds the LoA noise floor). If it says VO₂max equals 42 in absolute terms, the real lab value could be anywhere from about 36 to about 48. Use wearable VO₂max for am I trending up? Not for am I at the 75th percentile for my age?

INSCYD: different category. INSCYD (Switzerland-founded software, founded 2017 by Sebastian Weber, INSCYD GmbH registered in Salenstein, Switzerland) is not a wrist-worn estimate. It is a model-based metabolic-profile platform that ingests a structured 4 to 6-step submaximal field test (heart rate, power) and outputs estimated VO₂max, VLamax (maximal lactate production rate), FatMax, anaerobic threshold, and personalised training zones. Widely used in DACH cycling and triathlon coaching. Output is closer to lab Spiroergometrie than to a wrist-worn estimate, but still a model output, not a direct gas-exchange measurement. Typical 2026 DACH price for a coach-administered INSCYD test: €100 to €200.

Reference data for comparison. Loe H, Rognmo Ø, Saltin B, Wisløff U. 2013 PLoS ONE. The largest European VO₂max reference dataset: n = 3,816 healthy Norwegians (1,929 men plus 1,881 women) ages 20 to 90, all measured directly on treadmill CPET. Age 20 to 29 reference values: men 54.4 ± 8.4, women 43.0 ± 7.7. Decline about 3.5 per decade for both sexes. HRmax dropped about 6 beats per minute per decade. This is the dataset wearables and online "fitness age" calculators use behind their comparisons. Telling a 60-year-old man his VO₂max of 42 is "above average for his age" only means something if you cite Loe 2013 as the comparator and concede the wearable's ±10 LoA.

The longevity-curious reader is rarely a competitive endurance athlete. Still, the cardiac-safety literature on extreme endurance volumes is worth knowing. It frames proportionate caution and pushes back on the rare "endurance training causes heart damage" overcorrection.

The AFib signal in extreme endurance volumes. Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaëlsson K, Sundström J. 2013 European Heart Journal to 3631. Vasaloppet cohort, n = 52,755 male long-distance cross-country skiers (90 km Vasaloppet, enrolled 1989 to 1998, followed to 2005):

• 5 or more completed races vs 1 race: HR 1.29 (95% CI 1.04 to 1.61) for atrial fibrillation
• Faster finishing times (100 to 160% vs over 240% of winning time): HR 1.20 (0.93 to 1.55), CI crosses unity
• Sudden cardiac death rare, not significantly elevated

Mont L, Sambola A, Brugada J, et al. 2002 European Heart Journal to 482. Case-control, 70 patients with lone atrial fibrillation under age 65. 63% were long-term sportsmen versus 15% of matched controls (P < 0.05). Hypothesis-generating, small sample, but the originating paper for the AFib-in-endurance-athletes literature.

Aizer A, Gaziano JM, Cook NR, Manson JE, Buring JE, Albert CM. 2009 American Journal of Cardiology to 1577. Physicians' Health Study, n = 16,921 male physicians, 12-year follow-up, 1,661 incident AFib cases. Vigorous exercise 5 to 7 d per week versus less than 1 d per month: RR 1.20 (P = 0.04). Effect was largely confined to men under 50 and to joggers, and was attenuated in older men where the cardiometabolic benefits of vigorous exercise dominated.

Honest proportionate framing. The U-shape for AFib specifically is real but kicks in at very-high-volume endurance training (5 or more Vasaloppet 90 km finishes, decades of competitive endurance). It does not apply to a 3 to 6 hour per week Zone 2 plus 4×4 prescription in a 50-year-old DACH desk worker. The overall mortality benefit of being fit dwarfs the AFib signal across the typical longevity-curious reader profile (Kokkinos 2022 JACC found no increase in mortality at very high fitness levels. AFib is a specific arrhythmia signal, not a mortality signal). Frame it without scaremongering.

Right-ventricular strain in extreme endurance events. La Gerche A, Burns AT, Mooney DJ, et al. 2012 European Heart Journal to 1006. 40 endurance athletes scanned with cardiac MRI after a high-intensity endurance event. Right-ventricular ejection fraction dropped more than LVEF and recovered within about a week. A subset (5 of 39) showed late gadolinium enhancement localised to the interventricular septum. That subset had greater cumulative exercise exposure and lower RVEF. This is a hypothesis-generator about extreme volumes, not a reason to fear Zone 2. The category here is Ironman-level endurance and decades of accumulation, not weekly Zone 2.

Marathon-runner CAC paradox. Möhlenkamp S, Lehmann N, Breuckmann F, et al. 2008 European Heart Journal to 1910. Heinz Nixdorf Recall sub-study, n = 108 male marathon runners aged 50 and over with 5 or more marathons in the prior 3 years. Coronary artery calcium (CAC) was similar to age-matched controls but higher than Framingham-risk-matched controls. Four runners with CAC over 100 had coronary events during follow-up. The honest reading: marathon running does not erase atherosclerosis. High-volume endurance training in middle-aged men is associated with higher CAC than their lipid-and-BP-matched peers. The prognostic significance of this "athlete's CAC" pattern (more calcified, fewer non-calcified plaques, possibly more stable) is still debated. Pair the conversation with the ApoB and Lp(a) story. Fitness reduces cardiovascular risk. It does not abolish lipid-driven risk.

Pre-participation framework. Pelliccia 2020 Eur Heart J (cited in Section 8) is the ESC framework a DACH GP or Sportmediziner uses when an over-40 reader presents asking about starting an interval programme. History plus physical exam (Class IIa) for adults 35 and over starting vigorous exercise. An exercise test if there is CAD risk or symptoms. Routine ECG screening of asymptomatic low-risk adults is not universally recommended.

Special populations.

• Established cardiac disease (post-MI, HF, valvular disease, channelopathies): individualised prescription by a cardiologist. Wisløff 2007 Circulation showed 4×4 intervals at 95% peak HR were safely tolerated and dramatically effective in NYHA-class heart failure patients under supervised cardiac rehab. This is not a do-it-yourself prescription.
• Symptoms during exercise (chest pain, presyncope, exertional dyspnoea out of proportion to fitness): stop, get evaluated. Class I across all guidelines.
• Significant aortic stenosis, hypertrophic cardiomyopathy, channelopathies: individualised. Consult a specialist before starting.
• Asthma, COPD: spiroergometry actually helps quantify exercise capacity and guide prescription. Not a contraindication if controlled.
• Pregnancy: moderate aerobic exercise during an uncomplicated pregnancy is supported by current obstetric guidelines. High-intensity intervals require individualised obstetric input.

The broader picture: across almost every population, the cardiometabolic and mortality benefits of regular Zone 2 plus occasional intervals dwarf the specific arrhythmia or right-ventricular-strain risks. Those risks concentrate in extreme endurance volumes and decades-long competitive exposure. Frame the safety conversation proportionately.

Is cardiorespiratory fitness the strongest measured modifiable mortality predictor we have? Yes, in observational data. Mandsager 2018 JAMA Network Open (n = 122,007) puts the Low-vs-Elite CRF hazard ratio at 5.04, bigger than smoking, type 2 diabetes, or coronary artery disease in the same model. Kokkinos 2022 JACC (n = 750,302 veterans) replicates the gradient with no upper limit of benefit. Clausen 2018 JACC (46-year Copenhagen Male Study follow-up) partially addresses reverse causation. The effect held after excluding first-decade deaths. The AHA Scientific Statement (Ross 2016 Circulation) formally argues for CRF assessment as a clinical vital sign.

Is the interventional translation as strong as the observational gradient? Less clearly. Generation 100 (Stensvold 2020 BMJ), the only large RCT of structured exercise versus guidelines with all-cause mortality as the primary endpoint in older adults, was null on the primary endpoint at 5 years. HIIT versus MICT showed a non-significant trend (HR 0.51, P = 0.06). The trial was underpowered for absolute differences below one percentage point, and the control arm was already meeting national PA guidelines. The mechanism is solid. The cross-sectional CRF-mortality association is overwhelming. The interventional case needs honest framing.

Does Zone 2 specifically train mitochondria in a way HIIT cannot? Not in directly comparative human evidence. MacInnis & Gibala 2017 J Physiol plus Burgomaster 2008 J Physiol show that SIT and HIIT produce comparable mitochondrial-content adaptations to MICT at about a third of the time. The honest Zone 2 defence is volume-based: Zone 2 is the highest tolerable training volume, and total volume drives total mitochondrial content. The popular framing that Zone 2 uniquely targets the lactate-clearance machinery is mechanistically plausible (Brooks 2018 Cell Metabolism, San-Millán & Brooks 2018 Sports Med) but not proven against equivalent-volume HIIT.

Is the 4×4 the most defensible interval protocol? Yes, by replicated trial evidence. Helgerud 2007 MSSE (+7.2% VO₂max in 8 weeks in healthy adults). Wisløff 2007 Circulation (+46% VO₂peak in heart failure). Bacon 2013 PLoS ONE meta-analysis (pooled VO₂max +0.51 L per minute, effect 0.86 SD). Stöggl & Sperlich 2014 Front Physiol (polarised RCT, +11.7% VO₂peak in trained athletes). Seiler 2010 IJSPP provides the 80/20 observational basis. The Attia framing (about 80% Zone 2 plus about 20% VO₂max via 4×4) ties these together consistently.

Where can you get tested in DACH and what does it cost? Spiroergometrie standalone €200 to €350 in Germany / CHF 300 to 450 in Switzerland Selbstzahler. Combined spiro plus lactate €250 to €350 / CHF 350 to 500. Verified providers include TU München Klinikum rechts der Isar Sportmedizin (over 8,000 tests per year), Charité Sportmedizin Berlin, OSP network, Schön Klinik München Harlaching, Deutsche Sporthochschule Köln, Massimo Köstl-Lenz Wien, Hirslanden (5 Swiss locations CHF 350 to 450), Balgrist Zürich (CHF 250 lactate / CHF 350 spiro), and The Longevity Practice Berlin/Frankfurt (from €249). Krankenkasse generally does not cover for healthy-adult longevity screening. Bonus programmes do not specifically reimburse Spiroergometrie.

Are wearable VO₂max estimates useful? Yes for trends. Weak for absolute values. Molina-Garcia 2022 Sports Med INTERLIVE meta-analysis: ±10 mL per kg per minute individual-level LoA. Apple Watch underestimates by about 6 mL per kg per minute on average (2025 PLOS ONE). Loe 2013 PLoS ONE is the Norwegian reference dataset behind the wearable "fitness age" comparisons. Trust the trend within yourself. Do not treat the absolute as clinical.

Is there a safety concern? A specific, extreme-volume one. The AFib signal in endurance athletes (Andersen 2013 Eur Heart J, Mont 2002, Aizer 2009) is real but concentrates in very-high-volume endurance training over decades (Vasaloppet 5-plus finishes, not 3 to 6 hours per week of Zone 2 plus 4×4). The Pelliccia 2020 Eur Heart J ESC framework recommends pre-participation history plus physical exam (Class IIa) for adults 35 and over starting vigorous exercise. Routine ECG screening of asymptomatic low-risk adults is Class III. Frame proportionately.

The single most honest editorial position this guide takes. Cardiorespiratory fitness is the strongest measured modifiable mortality marker in observational data. The mechanism (Holloszy 1967, Brooks 2018, Bishop & Granata 2014) is settled. The trainability of VO₂max via the 4×4 is the cleanest physiological-adaptation signal we have. The popularised "Zone 2 specifically buys you 10 extra healthy years" claim is mechanism plus observation plus popularisation. It is not RCT-proven. The single large RCT we have (Generation 100) was null on its primary endpoint. The exercise is still worth doing. The benefits at 150 to 300 minutes per week are well established for many endpoints, and the marginal cost is low. Do it for the right reasons, framed honestly. The wider exercise context sits in the Exercise guide. The Attia framing in detail is in the Outlive guide. The wearables and HRV context is in the HRV & Wearables guide.